Explore the full insider trade history of HCA Healthcare, Inc., a listed issuer based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, HCA Healthcare, Inc. has recorded 116 reports. Market capitalisation: €93.8bn. The latest transaction was filed on 17 May 2022 (Cession). Among the most active insiders: Englebright Jane D.. The full history is openly available.
25 of 116 declarations
HCA Healthcare, Inc. (ticker HCA) is one of the largest for-profit healthcare services groups listed in the United States, and it trades on the NYSE (United States). Headquartered in Nashville, Tennessee, the company was founded in 1968 by Dr. Thomas Frist Sr., Dr. Thomas Frist Jr., and Jack C. Massey. Its original mission was to create a new model for hospital care built on scale, operational discipline, and clinical quality. That founding ethos still shapes HCA Healthcare’s strategy today, making it a long-established benchmark in the U.S. hospital and acute-care market. ([hcahealthcare.com](https://hcahealthcare.com/about/our-history.dot?utm_source=openai)) HCA Healthcare operates an extensive healthcare network that includes hospitals, ambulatory surgery centers, freestanding emergency rooms, urgent care centers, physician clinics, and other outpatient care sites. Its footprint is concentrated primarily in the United States, with an additional presence in the United Kingdom. The company describes itself as a learning health system, using a very large volume of patient encounters to support clinical improvement, research, and operational efficiency. ([investor.hcahealthcare.com](https://investor.hcahealthcare.com/news/news-details/2026/HCA-Healthcare-Named-a-Worlds-Most-Admired-Company-by-Fortune-for-the-12th-Consecutive-Year/default.aspx?utm_source=openai)) From a competitive standpoint, HCA’s strengths are its scale, integrated delivery model, broad geographic reach, and ability to expand higher-acuity specialty services alongside outpatient care. The group has also invested in digital and clinical systems intended to improve care coordination and productivity across its network. For investors, this mix matters because it supports a diversified revenue base within a highly fragmented U.S. healthcare landscape, while also giving HCA leverage on purchasing, staffing, and network optimization. ([investor.hcahealthcare.com](https://investor.hcahealthcare.com/news/news-details/2024/HCA-Healthcare-Releases-2024-Annual-Impact-Report/default.aspx?utm_source=openai)) Recent developments underscore the company’s operating momentum and strategic priorities. In first-quarter 2026, HCA reported revenue of $19.109 billion, up 4.3% year over year, net income attributable to HCA of $1.620 billion, and operating cash flow up 22.0%. Management also noted modest growth in admissions and emergency-room visits, while citing seasonal and weather-related pressures on volumes. In 2025, HCA continued to highlight community investment, nursing education support, and healthcare workforce initiatives, reflecting both its social footprint and the labor challenges facing the sector. ([investor.hcahealthcare.com](https://investor.hcahealthcare.com/news/news-details/2026/HCA-Healthcare-Reports-First-Quarter-2026-Results/default.aspx?utm_source=openai))